Stem Cells in Amniotic Fluid As New Tools to Study Human Genetic Diseases

Overview

Journal Stem Cell Rev

Specialty Cell Biology

Date 2007 Oct 24

PMID 17955390

Citations 24

Authors

Nicol Siegel

Margit Rosner

Michaela Hanneder

Alessandro Valli

Markus Hengstschlager

Affiliations

Soon will be listed here.

Abstract

In future, the characterization and isolation of different human stem cells will allow the detailed molecular investigation of cell differentiation processes and the establishment of new therapeutic concepts for a wide variety of diseases. Since the first successful isolation and cultivation of human embryonic stem cells about 10 years ago, their usage for research and therapy has been constrained by complex ethical consideration as well as by the risk of malignant development of undifferentiated embryonic stem cells after transplantation into the patient's body. Adult stem cells are ethically acceptable and harbor a low risk of tumor development. However, their differentiation potential and their proliferative capacity are limited. About 4 years ago, the discovery of amniotic fluid stem cells, expressing Oct-4, a specific marker of pluripotent stem cells, and harboring a high proliferative capacity and multilineage differentiation potential, initiated a new and promising stem cell research field. In between, amniotic fluid stem cells have been demonstrated to harbor the potential to differentiate into cells of all three embryonic germlayers. These stem cells do not form tumors in vivo and do not raise the ethical concerns associated with human embryonic stem cells. Further investigations will reveal whether amniotic fluid stem cells really represent an intermediate cell type with advantages over both, adult stem cells and embryonic stem cells. The approach to generate clonal amniotic fluid stem cell lines as new tools to investigate molecular and cell biological consequences of human natural occurring disease causing mutations is discussed.

Citing Articles

Transcriptome research of human amniocytes identifies hub genes associated with developmental dysplasia in down syndrome.

Guo Z, Xiao H, Yang W, Li T, Hao B, Liao S Aging (Albany NY). 2023; 15(23):14086-14108.

PMID: 38095646 PMC: 10756088. DOI: 10.18632/aging.205291.

In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment.

Kao Y, Yen C, Fan H, Chen J, Chen M, Lan Y Int J Mol Sci. 2023; 24(22).

PMID: 38003601 PMC: 10670993. DOI: 10.3390/ijms242216411.

Combination of human platelet lysate and 3D gelatin scaffolds to enhance osteogenic differentiation of human amniotic fluid derived mesenchymal stem cells.

Yaja K, Aungsuchawan S, Narakornsak S, Pothacharoen P, Pantan R, Tancharoen W Heliyon. 2023; 9(8):e18599.

PMID: 37576189 PMC: 10413082. DOI: 10.1016/j.heliyon.2023.e18599.

Effect of Passage Number of Conditioned Medium Collected from Equine Amniotic Fluid Mesenchymal Stem Cells: Porcine Oocyte Maturation and Embryo Development.

Park A, Oh H, Ji K, Choi E, Kim D, Kim E Int J Mol Sci. 2022; 23(12).

PMID: 35743012 PMC: 9224282. DOI: 10.3390/ijms23126569.

Amniotic Fluid Stem Cells: What They Are and What They Can Become.

Rosner M, Hengstschlager M Curr Stem Cell Res Ther. 2021; 18(1):7-16.

PMID: 34895127 DOI: 10.2174/1574888X16666211210143640.

References

Whitsett C, Priest J, PRIEST R, Marion J . HLA typing of cultured amniotic fluid cells. Am J Clin Pathol. 1983; 79(2):186-94. DOI: 10.1093/ajcp/79.2.186. View

Prusa A, Marton E, Rosner M, Freilinger A, Bernaschek G, Hengstschlager M . Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts. J Neural Transm Suppl. 2004; (67):235-42. DOI: 10.1007/978-3-7091-6721-2_21. View

Shamblott M, Axelman J, LITTLEFIELD J, Blumenthal P, Huggins G, Cui Y . Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci U S A. 2001; 98(1):113-8. PMC: 14553. DOI: 10.1073/pnas.98.1.113. View

Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S . Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 2006; 16(4):329-36. DOI: 10.1038/sj.cr.7310043. View

Wei J, Zhang T, Kawa S, Aizawa T, Ota M, Akaike T . Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant. 2003; 12(5):545-52. DOI: 10.3727/000000003108747000. View

Sakuragawa N, Elwan M, Fujii T, Kawashima K . Possible dynamic neurotransmitter metabolism surrounding the fetus. J Child Neurol. 1999; 14(4):265-6. DOI: 10.1177/088307389901400410. View

Prusa A, Marton E, Rosner M, Bettelheim D, Lubec G, Pollack A . Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol. 2004; 191(1):309-14. DOI: 10.1016/j.ajog.2003.12.014. View

Uchida S, Inanaga Y, Kobayashi M, Hurukawa S, Araie M, Sakuragawa N . Neurotrophic function of conditioned medium from human amniotic epithelial cells. J Neurosci Res. 2000; 62(4):585-90. DOI: 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U. View

Marx C, Vance B, Jarskog L, Chescheir N, Gilmore J . Nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 levels in human amniotic fluid. Am J Obstet Gynecol. 1999; 181(5 Pt 1):1225-30. DOI: 10.1016/s0002-9378(99)70113-4. View

10.

Monk M, Holding C . Human embryonic genes re-expressed in cancer cells. Oncogene. 2002; 20(56):8085-91. DOI: 10.1038/sj.onc.1205088. View

11.

Kaviani A, Perry T, Dzakovic A, Jennings R, ZIEGLER M, Fauza D . The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001; 36(11):1662-5. DOI: 10.1053/jpsu.2001.27945. View

12.

Prusa A, Hengstschlager M . Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit. 2002; 8(11):RA253-7. View

13.

Miki T, Lehmann T, Cai H, Stolz D, Strom S . Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005; 23(10):1549-59. DOI: 10.1634/stemcells.2004-0357. View

14.

Kunisaki S, Freedman D, Fauza D . Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. J Pediatr Surg. 2006; 41(4):675-82. DOI: 10.1016/j.jpedsurg.2005.12.008. View

15.

De Coppi P, Callegari A, Chiavegato A, Gasparotto L, Piccoli M, Taiani J . Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol. 2006; 177(1):369-76. DOI: 10.1016/j.juro.2006.09.103. View

16.

Rehni A, Singh N, Jaggi A, Singh M . Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav Brain Res. 2007; 183(1):95-100. DOI: 10.1016/j.bbr.2007.05.028. View

17.

Rosenthal N . Prometheus's vulture and the stem-cell promise. N Engl J Med. 2003; 349(3):267-74. DOI: 10.1056/NEJMra020849. View

18.

Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, Benvenisty N . Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol. 2001; 11(7):514-8. DOI: 10.1016/s0960-9822(01)00144-0. View

19.

Jones D, Anderson E, Galvin K . Spinal cord regeneration: moving tentatively towards new perspectives. NeuroRehabilitation. 2004; 18(4):339-51. View

20.

Fuchs J, Kaviani A, Oh J, LaVan D, Udagawa T, Jennings R . Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg. 2004; 39(6):834-8. DOI: 10.1016/j.jpedsurg.2004.02.014. View